N-acetylneuraminic acid transport by Streptococcus oralis strain AR3

Journal of Medical Microbiology

Volumn 48, Issue 4, 1999, Pages 375-381

  Byers, H L ^a   Homer, K A ^a   Tarelli, E ^a   Beighton, D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; CARBOHYDRATE; CARBON 14; CHLORHEXIDINE; FLUORIDE SODIUM; GLYCOPROTEIN; MANNOSAMINE; N ACETYLGLUCOSAMINE; N ACETYLNEURAMINIC ACID; NEURAMINIC ACID; PERMEASE; SIALIC ACID DERIVATIVE; SIALIDASE; SUGAR;

ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; CONTROLLED STUDY; FERMENTATION; HUMAN; IMMUNE DEFICIENCY; KINETICS; PRIORITY JOURNAL; PROTON MOTIVE FORCE; SEPTICEMIA; SERUM; STREPTOCOCCUS ORALIS;

EID: 0032858833     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-4-375     Document Type: Article

References (45)

1. Bochud P-Y, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 1994; 97: 256-264.
2. Bochud P-Y, Eggiman P, Calandra T, van Melle G, Saghafi L, Francioli P. Bacteremia due to viridans streptococccus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 1994b; 18: 25-31.
3. Douglas CWI. Pathogenic mechanisms in infective endocarditis. Rev Med Microbiol 1993; 4: 130-137.
4. Awada A, van ber Auwera P, Meunier F, Daneau D, Klastersky J. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis 1992; 15: 33-48.
5. Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DAG. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 1983; 2: 1452-1454.
6. McWhinney PH, Patel S, Whiley RA, Hardie JM, Gillespie SH, Kibbler CC. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob Agents Chemother 1993; 37: 2493-2495.
7. Beighton D, Hardie JM, Whiley RA. A scheme for the identification of viridans streptococci. J Med Microbiol 1991; 35: 367-372.
8. Kilian M, Mikkelsen L, Henrichsen J. Taxonomic study of viridans streptococci: description of Streptococcus gordonii sp. nov. and emended descriptions of Streptococcus sanguis (White and Niven 1946), Streptococcus oralis (Bridge and Sneath 1982), and Streptococcus mitis (Andrewes and Horder 1906). Int J Syst Bacteriol 1989; 39: 471-484.
9. Beighton D, Carr AD, Oppenheim BA. Identification of viridans streptococci associated with bacteraemia in neutropenic cancer patients. J Med Microbiol 1994; 40: 202-204.
10. Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM. Streptococcus intermedius, Streptococcus consellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 1992; 30: 243-244.
11. Jacobs JA, Schouten HC, Stobberingh EE, Soeters PB. Viridans streptococci isolated from the bloodstream. Relevance of species identification. Diagn Microbiol Infect Dis 1995; 22: 267-273.
12. Hardie JM, Whiley RA. Recent developments in streptococcal taxonomy: their relation to infections. Rev Med Microbiol 1994; 5: 151-162.
13. Douglas CWI, Heath J, Hampton KK, Preston FE. Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol 1993; 39: 179-182.
14. Bouvet A, Durand A, Devine C, Etiènne J, Leprot C, Groupe D'Enquëte sur l'Endocardité en France en 1990-1991. In vitro susceptibility to antibiotics of 200 strains of streptococci and enterococci isolated during infective endocarditis. In: Totolian A (ed) Pathogenic streptococci: present and future. Proceedings of the XII Lancefield International Symposium of Streptococci and Streptococcal Diseases. St Petersberg, Russia, Lancer Publications. 1994: 72-73.
15. Heimdahl A, Mattsson T, Dahllof G, Lonnquist B, Ringden O. The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1989; 68: 711-715.
16. Ruoff KL. Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen. Clin Microbiol Rev 1988; 1: 102-108.
17. Crawford I, Russell C. Comparative adhesion of seven species of streptococci isolated from the blood of patients with sub-acute bacterial endocarditis to fibrin-platelet clots in vitro. J Appl Bacteriol 1986; 60: 127-133.
18. Scheld WM, Valone JA, Sande MA. Bacterial adherence in the pathogenesis of endocarditis. J Clin Invest 1978; 61: 1394-1404.
19. Gossling J. Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis 1988; 10: 257-285.
20. Douglas CWI, Brown PR, Preston FE. Platelet aggregation by oral streptococci. FEMS Microbiol Lett 1990; 60: 63-67.
21. Reinholdt J, Tomana M, Mortensen SB, Kilian M. Molecular aspects of immunoglobulin A1 degradation by oral streptococci. Infect Immun 1990; 58: 1186-1194.
22. Rafay AM, Homer KA, Beighton D. Effect of mucin and glucose on proteolytic and glycosidic activities of Streptococcus oralis. J Med Microbiol 1996; 44: 409-417.
23. van der Hoeven JS, Camp PJ. The use of lectins in monitoring degradation of oligosaccharide chains in mucin by oral streptococci. Caries Res 1994; 28: 257-261.
24. van der Hoeven JS, Camp PJ, Synergistic degradation of mucin by Streptococcus oralis and Streptococcus sanguis in mixed chemostat cultures. J Dent Res 1991; 70: 1041-1044.
25. Schauer R. Origin and biological role of the great chemical diversity of natural sialic acids. Trends Glycosci Glycotech 1997; 9: 315-330.
26. Schauer R, Kelm S, Reuter G, Roggentin P, Shaw L. Biochemistry and role of sialic acids. In: Rosenberg A (ed) Biology of the sialic acids. New York, Plenum Press. 1995: 7-67.
27. Byers HL, Homer KA, Beighton D. Utilization of sialic acid by viridans streptococci. J Dent Res 1996; 75: 1564-1571.
28. Homer KA, Kelley S, Hawkes J, Beighton D, Grootveld MC. Metabolism of glycoprotein-derived sialic acid and N-acetylglucosamine by Streptococcus oralis. Microbiology 1996; 142: 1221-1230.
29. Rodriguez-Aparicio LB, Reglero A, Luengo JM. Uptake of N-acetylncurammic acid by Excherichia coli K-235. Biochemical characterization of the transport system. Biochem J 1987; 246: 287-294.
30. Andreadaki FJ, Kolisis FN, Sakellaris G, Evangelopoulos E. Incorporation studies of free N-acetylncuraminic acid and cytidine monophosphate-N-acetylneuraminic acid by intact cells of Lactobacillus plantarum. Biotechnol Appl Biochem 1990; 12: 653-660.
31. Joshi AK, Ahmed S, Ames GF-L. Energy coupling in bacterial periplasmic transport systems. Studies in intact Escherichia coli cells. J Biol Chem 1989; 264: 2126-2133.
32. Kuyyakanond T, Quesnel LB. The mechanism of action of chlorhexidine. FEMS Microbiol Lett 1992; 79: 211-215.
33. Sutton SVW, Bender GR, Marquis RE. Fluoride inhibition of proton-translocating ATPases of oral bacteria. Infect Immun 1987; 55: 2597-2603.
34. Parnes JR, Boos W. Energy coupling of the β-methylgalactoside transport system of Escherichia coil. J Biol Chem 1973; 248: 4429-35.
35. Kashket ER, Wilson TH. Proton-coupled accumulation of galactoside in Streptococcus lactis 7962. Proc Natl Acad Sci USA 1973; 70: 2866-2869.
36. Morgan MS, Darrow RM, Nafz MA, Varandani PT. Participation of cellular thiol/disulphide groups in the uptake, degradation and bioactivity of insulin in primary cultures of rat hepatocytes. Biochem J 1985; 225: 349-356.
37. Liberman ES, Bletweis AS. Transport of glucose and mannose by a common phosphoenolpyruvate-dependent phosphotransferase system in Streptococcus mutans GS5. Infect Immun 1984; 43: 1106-1109.
38. Homer KA, Patel R, Beighton D. Effects of N-acetylglucosamine on carbohydrate fermentation by Streptococcus mutans NCTC 10449 and Streptococcus sabrinus SL-1. Infect Immun 1993; 61: 295-302.
39. Martinez J, Steenbergen S, Vimr E. Derived structure of the putative sialic acid transporter from Excherichia coli predicts a novel sugar permease domain. J Bacteriol 1995; 177: 6005-6010.
40. Corfield T. Bacterial sialidases - roles in pathogenicity and nutrition. Glycobiology 1992; 2: 509-521.
41. Godoy VG, Dallas MM, Russo TA, Malamy MH. A role for Bacteroides fragilis neuraminidase in bacterial growth in two model systems. Infect Immun 1993; 61: 4415-4426.
42. Nees S, Schauer R. Induction of neuraminidase from Clostridium perfringens and the co-operation of this enzyme with acylneuraminate pyruvate-lyase. Behring Inst Mitt 1974; 55: 68-78.
43. Vimr ER, Troy FA. Identification of an inducible catabolic system for sialic acids (nan) in Escherichia coli. J Bacteriol 1985; 164: 845-853.
44. Homer KA, Whiley RA, Beighton D. Production of specific glycosidase activities by Streptococcus intermedius strain UNS35 grown in the presence of mucin. J Med Microbiol 1994; 41: 184-190.
45. Baddour LM. Virulence factors among Gram-positive bacteria in experimental endocarditis. Infect Immun 1994; 62: 2143-2148.